SYK AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

The stock holds a moderate value rating. If you have positions, consider retaining; for new ones, wait for a value score above 4.

SYK Current Performance

1.29%

Stryker corporation

1.19%

Avg of Sector

1.11%

S&P500

Top 10 High Relevance to SYK

  • BSX Boston scientific corporation
    Value 4Trend 3Swing Trading 2Whale Interest 3Dividend 1
    See more

SYK Profile

Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It also specializes in soft tissue fixation products.

Price of SYK